Neo Ivy Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Neo Ivy Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$698K	Sell	1,421 -9,671	-87%	-$5.25M	0.18%	180
2025 Q4	$6.43M	Buy	11,092 +6,320	+132%	+$3.57M	1.02%	12
2025 Q3	$2.31M	Buy	4,772 +3,865	+426%	+$1.8M	0.56%	56
2025 Q2	$368K	Buy	+907	New	+$379K	0.12%	234
2021 Q2	–	Sell	-610	Closed	-$278K	–	610
2021 Q1	$278K	Sell	610 -37	-6%	-$17.7K	0.3%	115
2020 Q4	$301K	Buy	+647	New	+$303K	0.34%	104
2020 Q2	–	Sell	-1,775	Closed	-$503K	–	598
2020 Q1	$503K	Buy	+1,775	New	+$560K	0.82%	7

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neo Ivy Capital Management's TMO Position: Q1 2026 in Review

Neo Ivy Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 87% in Q1 2026, selling an estimated $5.25M and leaving 1,421 shares worth $698K. The position accounts for 0.18% of the portfolio, ranked #180.

Neo Ivy Capital Management first reported a position in TMO in Q1 2020 and has held it in 7 quarters since. The position peaked at $6.43M in Q4 2025. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Neo Ivy Capital Management held 1,421 shares of Thermo Fisher Scientific worth $698K as of Q1 2026.
Neo Ivy Capital Management sold 9,671 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.25M.
Thermo Fisher Scientific made up 0.18% of Neo Ivy Capital Management's portfolio in Q1 2026, its #180 holding.
Neo Ivy Capital Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 7 quarters since.
Neo Ivy Capital Management's Thermo Fisher Scientific position peaked at $6.43M in Q4 2025.
2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.